Dr. Lal Pathlabs Limited — Capital/Financing Update 2020

Feb 3, 2020

==> picture [288 x 41] intentionally omitted <==

February 3, 2020

National Stock Exchange of India Limited SSE Limited Exchange Plaza, Corporate Relationship Department Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers Sandra Kurla Complex Dalal Street Sandra (E) Mumbai- 400001 Mumbai - 400 051.

Subject: Intimation under Regulation 30(2) of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015

Dear Sir / Madam,

Please take note that the Board of Directors of the Company's Wholly Owned Subsidiary PathLabs Unifiers Private Limited, in their meeting held on Monday, February 03, 2020 approved signing a binding term sheet for acquisition of following Proprietorship Concerns, namely:

• 1) M/s Shree Computerised Pathology Laboratory

• 2) M/s Modern Diagnostics & Modern Lab

The details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 are provided in the Annexure I attached to this letter.

We request you to kindly take the same on record.

Thanking You,

Yours Faithfully, Rajat Ka a Company Secretary & Legal Head

==> picture [76 x 78] intentionally omitted <==

Encl.: As above

E-m.>;I: lalµat[t] ,;at·��•!alpJthlabs.com, Web: www.lalpathlabs com, CIN No.: L7'1;'"'7DL 1995PLC065388

R�d. Office: Dr. Lal Pdlt1Lab� Li:; .. Bir,:!< E, Sator-18, Rot,:.:,, New De!t:i • 110085, +91-1 1-3025&.-00. Fax: +o 1-l l-2788-2134 Corporate Office: Dr l;il Pdthl.::t:; Ltd., 12th f;.�.[-] .,, Tower B, SAS Tower. M"'1;, ity, Sector-38, Gurugram - 122 001, Harydna +91-124-3016-500. Fax: +91-124-4234-468

"a.

Annexure I

			Annexure I
Sr. No.	Particulars in respect of the Event		Details/ Information of the Event
1.	Name of the target entity, details in brief such as size, turnover etc.		Name: 1) M/s Shree Computerised Pathology Laboratory 2) M/s Modern Di1gnostics & Modern Lab Turnover:As detailed in Annexure 'II'
2.	Whether the acquisition would fall within related party transaction(s) and whether t_he promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereofand whetherthe same is done at"arm'slenqth";		No, the transactionsare not related party transactions.
3.	Industry to which the entity beinq acquired belonqs.		Healthcare/ Diaqnostics
4 ..	Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity);		To strengthen the Company'spresence in the state of Maharashtra.
5.	Briefdetails of anygovernmentalorregulatory approvals required for the acquisition		No government approvals required
6.	Indicative time periodfor completion ofthe acquisition		Within3 month
7.	Nature of consideration - whether cash consideration or share swap and details ofthe same		Cash consideration
8.	Cost of acquisition or the price at which the shares are acquired		1) M/sShreeComputerised Pathology Laboratory - Not exceeding Rs. 4.1 Cr. 2) Mis Modern Diagnostics & Modern Lab - Not exceeding Rs. 3.6 Cr.
9.	Percentage of shareholding / control acquired and / or number of shares acquired;		Complete Control
10.	Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information		M/s Shree Computerised Pathology Laboratory and M/s Modern Diagnostics & Modern Lab provide pathological testing services in the district of Yavatmal and Sang Ii respectively in the state of Maharashtra. Turnover: Please refer to Annexure 'II'.

Annexure 'II' Turnover for FY16-17, FY17-18 and FY18-19

Turnover for FY16-17, FY17-18 and FY18-19	Turnover for FY16-17, FY17-18 and FY18-19	Turnover for FY16-17, FY17-18 and FY18-19	Turnover for FY16-17, FY17-18 and FY18-19
(INR in Cr.)
SI. No.	Name of entities	FY16-17 FY17-18	FY18-19
1	Mis Shree Computerised Pathology Laborator	NA 1.25	1.57
2	M/s Modern Diagnostics & Modern Lab	NA 1.31	1.65

==> picture [77 x 80] intentionally omitted <==

==> picture [69 x 56] intentionally omitted <==